Cargando…
The impact of COVID‐19 pandemic on pulmonary hypertension: What have we learned?
The coronavirus 2019 disease (COVID‐19) pandemic threatened the Spanish health‐care system. Patients with demanding conditions such as precapillary pulmonary hypertension (PH) faced a potentially severe infection, while their usual access to medical care was restricted. This prospective, unicentric...
Autores principales: | Hinojosa, Williams, Cristo‐Ropero, María José, Cruz‐Utrilla, Alejandro, Segura de la Cal, Teresa, López‐Medrano, Francisco, Salguero‐Bodes, Rafael, Pérez‐Olivares, Carmen, Navarro, Begoña, Ochoa, Nuria, Arribas Ynsurriaga, Fernando, Escribano‐Subias, Pilar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537953/ https://www.ncbi.nlm.nih.gov/pubmed/36238968 http://dx.doi.org/10.1002/pul2.12142 |
Ejemplares similares
-
The role of cardiopulmonary exercise testing in identifying and monitoring pulmonary veno-oclusive disease: a case report
por: Segura de la Cal, Teresa, et al.
Publicado: (2022) -
COVID-19 Experience and Pulmonary Arterial Hypertension: Do Earlier Theses and New Data Still Match?
por: Segura de la Cal, Teresa, et al.
Publicado: (2021) -
Curso clínico de la COVID-19 en pacientes con hipertensión arterial pulmonar
por: Nuche, Jorge, et al.
Publicado: (2020) -
Clinical course of COVID-19 in pulmonary arterial hypertension patients
por: Nuche, Jorge, et al.
Publicado: (2020) -
Sex Differences in Chronic Thromboembolic Pulmonary Hypertension. Treatment Options over Time in a National Referral Center
por: Cruz-Utrilla, Alejandro, et al.
Publicado: (2021)